NO304189B1 - FremgangsmÕte for fremstilling av et terapeutisk aktivt polypeptid som har minst en epitop fra P14-allergenet fra planter, rekombinant DNA-molekyl, replikerbar mikrobiell ekspresjonsvektor, vertsorganisme, samt anvendelse av polypeptidet - Google Patents
FremgangsmÕte for fremstilling av et terapeutisk aktivt polypeptid som har minst en epitop fra P14-allergenet fra planter, rekombinant DNA-molekyl, replikerbar mikrobiell ekspresjonsvektor, vertsorganisme, samt anvendelse av polypeptidet Download PDFInfo
- Publication number
- NO304189B1 NO304189B1 NO921375A NO921375A NO304189B1 NO 304189 B1 NO304189 B1 NO 304189B1 NO 921375 A NO921375 A NO 921375A NO 921375 A NO921375 A NO 921375A NO 304189 B1 NO304189 B1 NO 304189B1
- Authority
- NO
- Norway
- Prior art keywords
- polypeptide
- ige
- allergen
- birch
- pollen
- Prior art date
Links
- 239000013566 allergen Substances 0.000 title claims abstract description 69
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 60
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 59
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 58
- 108020004511 Recombinant DNA Proteins 0.000 title claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 title claims description 9
- 239000013604 expression vector Substances 0.000 title claims description 5
- 102000053602 DNA Human genes 0.000 title claims description 4
- 230000000813 microbial effect Effects 0.000 title claims 4
- 235000018185 Betula X alpestris Nutrition 0.000 claims abstract description 69
- 235000018212 Betula X uliginosa Nutrition 0.000 claims abstract description 69
- 238000000034 method Methods 0.000 claims abstract description 24
- 108020004414 DNA Proteins 0.000 claims abstract description 13
- 241000196324 Embryophyta Species 0.000 claims abstract description 13
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 13
- 241000219427 Fagales Species 0.000 claims abstract description 9
- 210000002966 serum Anatomy 0.000 claims description 32
- 241000588724 Escherichia coli Species 0.000 claims description 29
- 240000007582 Corylus avellana Species 0.000 claims description 16
- 235000007466 Corylus avellana Nutrition 0.000 claims description 16
- 235000001543 Corylus americana Nutrition 0.000 claims description 15
- 241000726768 Carpinus Species 0.000 claims description 9
- 244000025254 Cannabis sativa Species 0.000 claims description 6
- 241000219492 Quercus Species 0.000 claims description 4
- 230000004071 biological effect Effects 0.000 claims description 3
- 241000565357 Fraxinus nigra Species 0.000 claims description 2
- 241000124008 Mammalia Species 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 230000008105 immune reaction Effects 0.000 claims 1
- 230000002103 transcriptional effect Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 abstract description 70
- 102000004169 proteins and genes Human genes 0.000 abstract description 59
- -1 poly(L-proline) Polymers 0.000 abstract description 28
- 208000026935 allergic disease Diseases 0.000 abstract description 14
- 108010026466 polyproline Proteins 0.000 abstract description 13
- 238000002560 therapeutic procedure Methods 0.000 abstract description 13
- 238000000746 purification Methods 0.000 abstract description 12
- 238000003745 diagnosis Methods 0.000 abstract description 5
- 102000039446 nucleic acids Human genes 0.000 abstract description 5
- 108020004707 nucleic acids Proteins 0.000 abstract description 5
- 150000007523 nucleic acids Chemical class 0.000 abstract description 5
- 235000009109 Betula pendula Nutrition 0.000 abstract description 4
- 241000219430 Betula pendula Species 0.000 abstract description 3
- 230000002068 genetic effect Effects 0.000 abstract description 3
- 102100031109 Beta-catenin-like protein 1 Human genes 0.000 description 101
- 108050001408 Profilin Proteins 0.000 description 59
- 102000011195 Profilin Human genes 0.000 description 59
- 239000002299 complementary DNA Substances 0.000 description 40
- 229960004784 allergens Drugs 0.000 description 29
- 230000000172 allergic effect Effects 0.000 description 24
- 208000010668 atopic eczema Diseases 0.000 description 23
- 102000037865 fusion proteins Human genes 0.000 description 19
- 108020001507 fusion proteins Proteins 0.000 description 19
- 239000000020 Nitrocellulose Substances 0.000 description 16
- 229920001220 nitrocellulos Polymers 0.000 description 16
- 238000003119 immunoblot Methods 0.000 description 14
- 230000007815 allergy Effects 0.000 description 13
- 239000013612 plasmid Substances 0.000 description 13
- 206010020751 Hypersensitivity Diseases 0.000 description 12
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 11
- 241000282414 Homo sapiens Species 0.000 description 11
- 239000000284 extract Substances 0.000 description 10
- 240000004350 Prunus spinosa Species 0.000 description 9
- 235000010829 Prunus spinosa Nutrition 0.000 description 9
- 239000013575 birch pollen allergen Substances 0.000 description 9
- 239000013573 pollen allergen Substances 0.000 description 9
- 229920002401 polyacrylamide Polymers 0.000 description 9
- 240000007087 Apium graveolens Species 0.000 description 8
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 8
- 235000010591 Appio Nutrition 0.000 description 8
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 125000003275 alpha amino acid group Chemical group 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 239000003550 marker Substances 0.000 description 8
- 239000002773 nucleotide Substances 0.000 description 8
- 125000003729 nucleotide group Chemical group 0.000 description 8
- 108091033319 polynucleotide Proteins 0.000 description 8
- 102000040430 polynucleotide Human genes 0.000 description 8
- 239000002157 polynucleotide Substances 0.000 description 8
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 7
- 238000002405 diagnostic procedure Methods 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 238000009396 hybridization Methods 0.000 description 7
- 230000009257 reactivity Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 6
- 241000276498 Pollachius virens Species 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 6
- 229920002684 Sepharose Polymers 0.000 description 6
- 230000009260 cross reactivity Effects 0.000 description 6
- 229940046536 tree pollen allergenic extract Drugs 0.000 description 6
- 206010003645 Atopy Diseases 0.000 description 5
- 108091026890 Coding region Proteins 0.000 description 5
- 238000001042 affinity chromatography Methods 0.000 description 5
- 230000002009 allergenic effect Effects 0.000 description 5
- 230000004927 fusion Effects 0.000 description 5
- 241000224422 Acanthamoeba Species 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 4
- 244000309466 calf Species 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000009169 immunotherapy Methods 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 241000219495 Betulaceae Species 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241000746983 Phleum pratense Species 0.000 description 3
- 206010048908 Seasonal allergy Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 230000001363 autoimmune Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 229940046528 grass pollen Drugs 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 229940046166 oligodeoxynucleotide Drugs 0.000 description 3
- 201000004338 pollen allergy Diseases 0.000 description 3
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- 208000012657 Atopic disease Diseases 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 230000007023 DNA restriction-modification system Effects 0.000 description 2
- 241000283074 Equus asinus Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 244000082988 Secale cereale Species 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012149 elution buffer Substances 0.000 description 2
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000000984 immunochemical effect Effects 0.000 description 2
- 230000001320 lysogenic effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 108010087325 profilactin Proteins 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 241000219498 Alnus glutinosa Species 0.000 description 1
- 108010039627 Aprotinin Proteins 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 235000004355 Artemisia lactiflora Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000003932 Betula Nutrition 0.000 description 1
- 241000219429 Betula Species 0.000 description 1
- 244000274847 Betula papyrifera Species 0.000 description 1
- 235000009113 Betula papyrifera Nutrition 0.000 description 1
- 235000010928 Betula populifolia Nutrition 0.000 description 1
- 235000002992 Betula pubescens Nutrition 0.000 description 1
- 238000006027 Birch reduction reaction Methods 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 102100021238 Dynamin-2 Human genes 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 108010058643 Fungal Proteins Proteins 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101000817607 Homo sapiens Dynamin-2 Proteins 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 102000028554 IgE binding proteins Human genes 0.000 description 1
- 108091009324 IgE binding proteins Proteins 0.000 description 1
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 239000007990 PIPES buffer Substances 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 241000238711 Pyroglyphidae Species 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 102000005937 Tropomyosin Human genes 0.000 description 1
- 108010030743 Tropomyosin Proteins 0.000 description 1
- 241001661641 Verrucosa Species 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 1
- 238000001261 affinity purification Methods 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960004405 aprotinin Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- PXXJHWLDUBFPOL-UHFFFAOYSA-N benzamidine Chemical compound NC(=N)C1=CC=CC=C1 PXXJHWLDUBFPOL-UHFFFAOYSA-N 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000003837 chick embryo Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 238000003936 denaturing gel electrophoresis Methods 0.000 description 1
- 238000000586 desensitisation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 239000013024 dilution buffer Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 102000018146 globin Human genes 0.000 description 1
- 108060003196 globin Proteins 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000013574 grass pollen allergen Substances 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 229940046533 house dust mites Drugs 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 description 1
- 108010052968 leupeptin Proteins 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Automatic Disk Changers (AREA)
- Endoscopes (AREA)
- Mechanical Pencils And Projecting And Retracting Systems Therefor, And Multi-System Writing Instruments (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0168590A AT401180B (de) | 1990-08-13 | 1990-08-13 | Für das baumpollenallergen p14 codierende rekombinante dna-moleküle, daraus hergestellte und abgeleitete polypeptide und deren verwendung |
| US68383291A | 1991-04-11 | 1991-04-11 | |
| PCT/EP1991/001513 WO1992003551A1 (en) | 1990-08-13 | 1991-08-09 | Birch pollen allergen p14 for diagnosis and therapy of allergic diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO921375D0 NO921375D0 (no) | 1992-04-08 |
| NO921375L NO921375L (no) | 1992-06-12 |
| NO304189B1 true NO304189B1 (no) | 1998-11-09 |
Family
ID=25596534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO921375A NO304189B1 (no) | 1990-08-13 | 1992-04-08 | FremgangsmÕte for fremstilling av et terapeutisk aktivt polypeptid som har minst en epitop fra P14-allergenet fra planter, rekombinant DNA-molekyl, replikerbar mikrobiell ekspresjonsvektor, vertsorganisme, samt anvendelse av polypeptidet |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0495064B1 (fi) |
| JP (1) | JPH05502589A (fi) |
| AT (1) | ATE203055T1 (fi) |
| AU (1) | AU659609B2 (fi) |
| CA (1) | CA2067182A1 (fi) |
| DE (1) | DE69132653T2 (fi) |
| DK (1) | DK0495064T3 (fi) |
| FI (1) | FI104983B (fi) |
| NO (1) | NO304189B1 (fi) |
| WO (1) | WO1992003551A1 (fi) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0495052A1 (en) * | 1990-08-08 | 1992-07-22 | Biomay Biotechnik Produktions- Und Handelsgesellschaft M.B.H. | Allergens of alder pollen and applications thereof |
| US6982326B1 (en) | 1991-07-12 | 2006-01-03 | Immulogic Pharmaceutical Corporation | Allergenic proteins and peptides from Japanese cedar pollen |
| US6090386A (en) * | 1991-07-12 | 2000-07-18 | Griffith; Irwin J. | T cell peptides of the CRX JII allergen |
| WO1994011512A2 (en) * | 1992-11-12 | 1994-05-26 | Immulogic Pharmaceutical Corporation | Allergenic proteins and peptides from japanese cedar pollen |
| US5593877A (en) | 1993-03-11 | 1997-01-14 | The Rockefeller University | Nucleic acid and recombinant production of vespid venom hyaluronidase |
| WO1995019437A1 (en) * | 1994-01-14 | 1995-07-20 | University Of Manitoba | Cross-reactive allergen |
| AT402505B (de) * | 1995-08-02 | 1997-06-25 | Biomay Prod & Handel | Rekombinantes 60 kda pflanzliches panallergen (kofaktor-unabhängige phosphoglyceratmutase; e.c. 5.4.2.1.) |
| ES2125202B1 (es) * | 1997-06-24 | 2000-03-16 | Bial Ind Farmaceutica S A | Adn recombinante que codifica para epitopos del alergeno profilina util para el diagnostico y tratamiento de alergias. |
| ES2125201B1 (es) * | 1997-06-24 | 2000-03-16 | Bial Ind Farmaceutica S A | Adn recombinante que codifica para epitopos del alergeno mayor de olea europaea ole e 1 util para el diagnostico y tratamiento de alergias. |
| US7879977B2 (en) | 1998-01-31 | 2011-02-01 | University Of Arkansas | Methods and reagents for decreasing clinical reaction to allergy |
| AU743647B2 (en) | 1998-01-31 | 2002-01-31 | Mt. Sinai School Of Medicine Of New York University | Methods and reagents for decreasing allergic reactions |
| US8246945B2 (en) | 2000-04-06 | 2012-08-21 | University Of Arkansas | Methods and reagents for decreasing clinical reaction to allergy |
| DK1272213T3 (da) | 2000-04-06 | 2006-07-10 | Seer Pharmaceuticals Llc | Mikrobielt afgivelsessystem |
| ES2588756T3 (es) * | 2000-04-28 | 2016-11-04 | Novozymes A/S | Variante de enzima lipolítica |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3147763A1 (de) * | 1981-12-02 | 1983-06-09 | Stickl, Helmut, Prof.Dr.Med., 8033 Krailling | Nachweisverfahren zur in vitro-bestimmung des bei einer allergie korrespondierenden allergens |
| AT393137B (de) * | 1988-10-14 | 1991-08-26 | Biomay Biotech Prod | Verfahren zum screenen einer expressions-cdna- klonbank zur auffindung von polynukleotiden |
| EP0495052A1 (en) * | 1990-08-08 | 1992-07-22 | Biomay Biotechnik Produktions- Und Handelsgesellschaft M.B.H. | Allergens of alder pollen and applications thereof |
-
1991
- 1991-08-09 AU AU83901/91A patent/AU659609B2/en not_active Ceased
- 1991-08-09 DE DE69132653T patent/DE69132653T2/de not_active Expired - Lifetime
- 1991-08-09 EP EP91914581A patent/EP0495064B1/en not_active Expired - Lifetime
- 1991-08-09 CA CA002067182A patent/CA2067182A1/en not_active Abandoned
- 1991-08-09 DK DK91914581T patent/DK0495064T3/da active
- 1991-08-09 AT AT91914581T patent/ATE203055T1/de not_active IP Right Cessation
- 1991-08-09 WO PCT/EP1991/001513 patent/WO1992003551A1/en active IP Right Grant
- 1991-08-09 JP JP3513486A patent/JPH05502589A/ja active Pending
-
1992
- 1992-04-08 NO NO921375A patent/NO304189B1/no not_active IP Right Cessation
- 1992-04-10 FI FI921600A patent/FI104983B/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH05502589A (ja) | 1993-05-13 |
| WO1992003551A1 (en) | 1992-03-05 |
| DE69132653T2 (de) | 2002-05-08 |
| NO921375L (no) | 1992-06-12 |
| DE69132653D1 (de) | 2001-08-16 |
| EP0495064A1 (en) | 1992-07-22 |
| EP0495064B1 (en) | 2001-07-11 |
| CA2067182A1 (en) | 1992-02-14 |
| FI104983B (fi) | 2000-05-15 |
| ATE203055T1 (de) | 2001-07-15 |
| FI921600A (fi) | 1992-04-10 |
| NO921375D0 (no) | 1992-04-08 |
| AU659609B2 (en) | 1995-05-25 |
| FI921600A0 (fi) | 1992-04-10 |
| DK0495064T3 (da) | 2001-10-15 |
| AU8390191A (en) | 1992-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Valenta et al. | Profilins constitute a novel family of functional plant pan-allergens. | |
| US5583046A (en) | Birch pollen allergen P14 for diagnosis and therapy of allergic diseases | |
| DK174706B1 (da) | DNAsekvens, ekspressionsvektor, værtscelle, cDNA, fremgangsmåde til isolering og identificering af DNA samt anvendelse af DNA-sekvensen for et pollen allergen protein | |
| NO304189B1 (no) | FremgangsmÕte for fremstilling av et terapeutisk aktivt polypeptid som har minst en epitop fra P14-allergenet fra planter, rekombinant DNA-molekyl, replikerbar mikrobiell ekspresjonsvektor, vertsorganisme, samt anvendelse av polypeptidet | |
| JP2596466B2 (ja) | ダニの主要アレルゲンの還伝情報を有するｄｎａおよび該アレルゲンの製造方法 | |
| US6559120B2 (en) | Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments | |
| AU8311291A (en) | Allergens of alder pollen and applications thereof | |
| EP0803511A1 (en) | Allergenic proteins from ragweed and uses therefor | |
| KAUPPINEN et al. | Mutant derivatives of the main respiratory allergen of cow are less allergenic than the intact molecule | |
| JP5542685B2 (ja) | 新規な小麦アレルゲン | |
| US6335019B1 (en) | Methods for treating sensitivity to protein allergen using peptides which include a T cell epitope recognized by a T cell receptor specific for the protein allergen | |
| JP4253122B2 (ja) | アレルゲンの非アナフィラキシー形およびその使用 | |
| US7279295B2 (en) | Allergen | |
| JP4401288B2 (ja) | ヨモギ花粉由来のアレルゲン | |
| Mittermann et al. | Identification of a villin-related tobacco protein as a novel cross-reactive plant allergen | |
| WO1992016554A1 (en) | Protein allergens of the species cynodon dactylon | |
| EP1487869B1 (en) | Novel pollen allergen | |
| AT400198B (de) | Verwendung von poly(l-prolin) zur in vitro diagnose | |
| Stevens et al. | 18-kd allergen of birch (Betula verrucosa) pollen: ldentification as a cyclophilin | |
| Ferreira et al. | Profilins Constitute a Novel Family of Functional Plant Pan-allergens By Rudolf Valenta,* Michael Duchene,* Christof Ebner,* Peter Valent,~ Christian Sillaber,~ Philippe Deviller, $ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |